- Home
- PRSO vs MTNB Comparison
PRSO vs MTNB Comparison
Compare PRSO & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSO
- MTNB
- Stock Information
- Founded
- PRSO 2008
- MTNB 2013
- Country
- PRSO United States
- MTNB United States
- Employees
- PRSO N/A
- MTNB N/A
- Industry
- PRSO Semiconductors
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- PRSO Technology
- MTNB Health Care
- Exchange
- PRSO Nasdaq
- MTNB Nasdaq
- Market Cap
- PRSO 4.3M
- MTNB 3.6M
- IPO Year
- PRSO 2001
- MTNB N/A
- Fundamental
- Price
- PRSO $0.96
- MTNB $0.80
- Analyst Decision
- PRSO Strong Buy
- MTNB Hold
- Analyst Count
- PRSO 2
- MTNB 1
- Target Price
- PRSO $3.38
- MTNB N/A
- AVG Volume (30 Days)
- PRSO 196.1K
- MTNB 194.9K
- Earning Date
- PRSO 05-12-2025
- MTNB 05-15-2025
- Dividend Yield
- PRSO N/A
- MTNB N/A
- EPS Growth
- PRSO N/A
- MTNB N/A
- EPS
- PRSO N/A
- MTNB N/A
- Revenue
- PRSO $15,626,000.00
- MTNB N/A
- Revenue This Year
- PRSO $3.96
- MTNB N/A
- Revenue Next Year
- PRSO $36.80
- MTNB N/A
- P/E Ratio
- PRSO N/A
- MTNB N/A
- Revenue Growth
- PRSO 35.50
- MTNB N/A
- 52 Week Low
- PRSO $0.52
- MTNB $0.47
- 52 Week High
- PRSO $2.34
- MTNB $9.60
- Technical
- Relative Strength Index (RSI)
- PRSO 53.21
- MTNB 59.56
- Support Level
- PRSO $0.86
- MTNB $0.80
- Resistance Level
- PRSO $1.03
- MTNB $0.98
- Average True Range (ATR)
- PRSO 0.08
- MTNB 0.10
- MACD
- PRSO -0.00
- MTNB 0.00
- Stochastic Oscillator
- PRSO 44.60
- MTNB 54.17
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.